%0 Journal Article %A Benoit Borel %A Véronique Pepin %A Donald A. Mahler %A Éric Nadreau %A François Maltais %T Prospective validation of the endurance shuttle walking test in the context of bronchodilation in COPD %D 2014 %R 10.1183/09031936.00024314 %J European Respiratory Journal %P 1166-1176 %V 44 %N 5 %X This study focused on repeatability data and minimal important difference (MID) estimates of the endurance shuttle walking test (ESWT). 255 chronic obstructive pulmonary disease patients (forced expiratory volume in 1 s 54.7±13.2% predicted) completed four ESWTs at different times during the 8-week study: two under baseline conditions with tiotropium (1 week apart), one after a single dose and one after 4 weeks of either fluticasone propionate/salmeterol combination or placebo in addition to tiotropium. 97 patients performed all the tests with a portable metabolic system. Reproducibility of test performance and cardiorespiratory response was investigated with the data obtained on the first two ESWTs. The mean differences between the first two ESWT performances (-6.7±72.2 s and -7.3±113.1 m for endurance time and walking distance, respectively) were not statistically significant. The between-test end-exercise and isotime values for each cardiorespiratory parameter were not significantly different from each other. With the exception of arterial oxygen saturation by pulse oximetry, the repeatability of cardiorespiratory adaptations to ESWT was also confirmed with strong Pearson and intraclass correlation coefficients. Finally, changes of 56–61 s and 70–82 m in endurance time and distance walked, respectively, were perceived by patients. This study provides methodological information supporting the reliability of the ESWT and suggests MID estimates for this test. This study provides a prospective validation of ESWT reliability and minimal important difference in COPD http://ow.ly/zuLew %U https://erj.ersjournals.com/content/erj/44/5/1166.full.pdf